Your session is about to expire
← Back to Search
Enhanced DPP-GLB for Weight Loss Nonresponders
Study Summary
This trial will help to establish the efficacy of identifying weight loss nonresponders early and providing them with more intense personalized strategies.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are people currently being recruited to participate in this clinical trial?
"Yes, the information on clinicaltrials.gov says that this clinical trial is presently recruiting candidates. The clinical trial was first posted on 2/18/2021 and was last edited on 11/14/2022. The study is searching for 500 participants at 5 sites in order to test the efficacy of the proposed treatment."
How many people are expected to enroll in this study?
"That is accurate. The information available on clinicaltrials.gov reveals that this trial updated as recently as November 14th, 2022 and is still recruiting patients. They are looking for 500 individuals total, to be spread out across 5 different locations."
What are the main goals of this medical study?
"The purpose of this 12-week clinical trial is to observe changes in weight at the 6-month mark. Other secondary objectives include studying the impact of weight on quality of life (as measured by the Impact of Weight on Quality of Life Questionnaire) and changes in physical activity and blood pressure at the 12-week mark."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger